Anti-Human IFNA1 Therapeutic Antibody (Sifalimumab)
Recombinant human antibody to Human IFNA1. Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-H62 |
Pricing | Inquiry |
Host | human |
Target | IFNA1 |
Species Reactivity | Human |
Type | IgG1 - kappa |
Applications | ELISA, Inhib |